Biopharmaceutical company that develops, manufactures, and commercializes advanced cell therapies and specialty biologics for sports medicine and severe burn care
Biopharmaceutical company that develops, manufactures, and commercializes advanced cell therapies and specialty biologics for sports medicine and severe burn care. Its products include MACI, an autologous cell therapy for knee cartilage defects; Epicel, a cultured epidermal autograft for severe burns; and North American commercial rights to NexoBrid, an enzymatic treatment for burn eschar removal.